1. Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia;
2. Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada;
3. Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada;
4. Department for Biomedical Molecular Biology, Ghent University, Ghent, Belgium;
5. Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia;
6. Centre for Health Technologies and School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW, Australia;
7. Lowy Cancer Research Centre and Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia;
8. Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium;
9. Cancer Research Institute Ghent, Ghent, Belgium;
10. Department of Biomolecular Medicine, Ghent University, Ghent, Belgium;
11. Monash Bioinformatics Platform, Monash University, Melbourne, VIC, Australia;
12. Lowy Cancer Research Centre and School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia;
13. Department of Clinical Haematology, Alfred Health, Melbourne, Australia;
14. Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia;
15. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia;
16. Research Institute of Molecular Pathology, Vienna, Austria;
17. Department of Haematology, Prince of Wales Hospital, Randwick, NSW, Australia;
18. Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia; and
19. Department of Diagnostic Sciences, Ghent University, Ghent, Belgium;